April 29, 2020 / 10:05 PM / a month ago

BRIEF-Sumitovant Biopharma Reports Publication Of Myovant Abstracts

April 29 (Reuters) - Myovant Sciences Ltd:

* SUMITOVANT BIOPHARMA ANNOUNCES PUBLICATION OF MYOVANT ABSTRACTS DETAILING ADDITIONAL EFFICACY AND SAFETY FINDINGS FROM PHASE 3 LIBERTY STUDIES IN UTERINE FIBROIDS IN OBSTETRICS & GYNECOLOGY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below